{"id":"W3006115592","doi":"10.1097/01.hs9.0000560972.91141.2d","title":"PF672 RESULTS FROM ONGOING PHASE 1/2 CLINICAL TRIAL OF TAGRAXOFUSP (SL‐401) IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chronic myelomonocytic leukemia; Internal medicine; Refractory (planetary science); Oncology; Clinical trial; Interleukin-3 receptor; Gastroenterology; Leukemia; Myelodysplastic syndromes; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001081126,0.0004281335,0.001316892,0.0001554509,0.00004724231,0.00002783586,0.0003997151,0.0005196132,0.001027587],"category_scores_gemma":[0.001145912,0.0003432574,0.0002805921,0.0005858688,0.0002881154,0.0002409431,0.0002054962,0.001123113,0.0004945446],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01697989,"about_ca_system_score_gemma":0.01629385,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001963716,"about_ca_topic_score_gemma":0.0004920592,"domain_scores_codex":[0.9946379,0.0002905271,0.001820244,0.001090822,0.001334846,0.0008256297],"domain_scores_gemma":[0.9956293,0.001375506,0.0006077569,0.001736166,0.000249151,0.0004021889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8038009,0.008538579,0.0490432,0.001192693,0.0009487388,0.0007605178,0.001328681,0.0004114113,0.001053838,0.000114504,0.005983019,0.1268239],"study_design_scores_gemma":[0.9565445,0.01534216,0.01245309,0.001724343,0.0001786947,0.000008989168,0.0002259116,0.005544762,0.001158746,0.00003872668,0.006299883,0.0004802434],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892615,0.0004444624,0.00001777995,0.00006153676,0.0005424153,0.002555465,0.00008458445,0.00007554091,0.006956695],"genre_scores_gemma":[0.995699,0.0001375028,0.0005932775,0.00008312995,0.000551031,0.00004469621,0.0003475766,0.0001050547,0.002438731],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1527435,"threshold_uncertainty_score":0.999902,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03093092818752204,"score_gpt":0.3385047405346094,"score_spread":0.3075738123470874,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}